# EFI Lake Geneva Ventures

> EFI Lake Geneva Ventures is a VC fund in Geneva backing Health Care and Life Science. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Geneva, Switzerland
- Total investments: 7
- Last investment: Apr 2025
- Lead investor: 29%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/efi-lake-geneva-ventures
- Website: https://lakegenevaventures.com

EFI Lake Geneva Ventures is a seed and early-stage investment strategy.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2.5M–$3.8M |
| Series B | $5.1M–$16M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 5 | 71% |
| Life Science | 3 | 43% |
| Biotechnology | 2 | 29% |
| Medical Device | 2 | 29% |
| Medical | 1 | 14% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 43% |
| Series B | 2 | 29% |
| Pre-Seed | 1 | 14% |
| Series A | 1 | 14% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Switzerland | 6 | 86% |
| Germany | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Annaida Technologies | Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance (“µNMR”) at a scale 10-fold better than existing technologies. |  | Seed | Apr 29, 2025 |  |
| Hemotune | Hemotune is a medical device company that develops a therapeutic blood purification platform for treatment of health ailments. | $15.6M | Series B | Mar 25, 2024 |  |
| Hylomorph | Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices. The company was founded in 2014 and is headquartered in Zurich, Switzerland. | $5.1M | Series B | Sep 05, 2023 |  |
| EBAMed | EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware andsoftware components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients. | $15.7M | Series A | Jun 27, 2023 |  |
| Seprify | Impossible Materials envisions future customers consuming more sustainable products produced in a circular economy. They contribute to this future by selling cellulose-based products to businesses. Plant-based cellulose white pigment and opacifier solutions have been developed for a variety of industries. | $3.8M | Seed | Apr 05, 2023 |  |
| FluoSphera | FluoSphera is a discovery of efficient drugs with fewer adverse side effects and the reduction of animal experimentation, allowing companies to address the complexity of human physiological responses and protect populations from hazardous chemicals more effectively. | $1M | Pre-Seed | Mar 01, 2023 |  |
| Terapet | Terapet was founded at CERN by two physicists – Christina Vallgren and Marcus Palm – along with Professor Raymond Miralbell from the Geneva University Hospitals (HUG). They have already proven the feasibility of their concept and are now developing an initial version for market launch. | $2.5M | Seed | Feb 17, 2023 |  |

7 of 7 investments shown.

## Co-investors
- [Zürcher Kantonal Bank](https://shizune.co/investors/profile/z%C3%BCrcher-kantonalbank) — VC Fund, 3 deals together
- [Excellis](https://shizune.co/investors/profile/excellis) — VC Fund, 2 deals together
- [Hemex](https://shizune.co/investors/profile/hemex) — VC Fund, 2 deals together
- [OCCIDENT](https://shizune.co/investors/profile/occident-group) — VC Fund, 2 deals together
- [Apprecia Capital](https://shizune.co/investors/profile/apprecia-capital) — VC Fund, 1 deal together
- [Belmondo](https://shizune.co/investors/profile/belmondo-95f6) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [SICTIC](https://shizune.co/investors/profile/sictic) — VC Fund
- [Zürcher Kantonal Bank](https://shizune.co/investors/profile/z%C3%BCrcher-kantonalbank) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund

## Featured in investor lists
- [Health Care Investors in Switzerland](https://shizune.co/investors/health-care-investors-switzerland)
- [Life Science Investors in Switzerland](https://shizune.co/investors/life-science-investors-switzerland)

## FAQ

### What does EFI Lake Geneva Ventures invest in?

EFI Lake Geneva Ventures invests primarily in Health Care, Life Science and Biotechnology startups, most often at Seed and Series B stage. Most of the 7 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is EFI Lake Geneva Ventures's check size?

EFI Lake Geneva Ventures typically joins rounds of $2.5M–$3.8M at Seed and $5.1M–$16M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds EFI Lake Geneva Ventures participates in.

### When did EFI Lake Geneva Ventures last invest?

The most recent investment recorded for EFI Lake Geneva Ventures closed in Apr 2025. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co